Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders.

This study is currently recruiting participants.

Verified by Carmel Medical Center, December 2008

Sponsors and Collaborators:	Carmel Medical Center Soroka University Medical Center Technion, Israel Institute of Technology
Information provided by:	Carmel Medical Center
ClinicalTrials.gov Identifier:	NCT00705055

Purpose

The hypothesis to be tested: After the construction of a database of anthropometric measurements, the system would extract important features of a given facial surface and be able to match it with existing morphometric figures. A given combination of normal and abnormal measurements will open a "probable diagnosis" and a list of "differential diagnosis" that will be expressed as percent of matching in a descendent order to the examiner.

Condition
Genetic Disorders

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Face Anthropometric Pattern Recognition Technology, Based on 3D Reconstruction Technology, for Computer Aided Diagnosis of Human Genetic Disorders. Multicenter Collaborative Study.

Further study details as provided by Carmel Medical Center:

Primary Outcome Measures:

To create the bases for a "normal patterns" database [ Time Frame: unknown ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	800
Study Start Date:	November 2007
Estimated Study Completion Date:	November 2010
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts
1 Normal Male
2 Normal Female

Show Detailed Description

Eligibility

Ages Eligible for Study:	up to 2 Weeks
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Newborn infants born at Carmel Medical Center or at Soroka Medical Center

Criteria

Inclusion Criteria:

all newborn infants born at the Carmel Medical Center following parental consent, and at Soroka Medical Center.

Exclusion Criteria:

No parental consent; Facial deformation not related to chromosomal or genetic anomalies; babies transferred to the neonatal intensive care unit that need ventilatory support.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00705055

Contacts

Contact: Dan Waisman, MD	+972506265525	dwaisman@netvision.net.il
Contact: Tali Ben Ari, MsN	+972523653302	tali.ibclc@gmail.com

Locations

Israel
Department of Neonatology, Carmel Medical Center	Recruiting
Haifa, Israel
Contact: Dan Waisman, MD +972506265525 dwaisman@netvision.net.il
Principal Investigator: Dan Waisman, MD
Sub-Investigator: Irena Kessel, MD
Department of Neonatology, Soroka University Medical Center	Recruiting
Beer Sheva, Israel
Contact: Daniela Landau, MD +972544874910 danielala@clalit.org.il
Principal Investigator: Daniela Landau, MD

Sponsors and Collaborators

Carmel Medical Center

Soroka University Medical Center

Technion, Israel Institute of Technology

Investigators

Principal Investigator:

Dan Waisman, MD

Department of Neonatology, Carmel Medical Center

More Information

Responsible Party:	Department of Neonatology, Carmel Medical Center ( Dan Waisman, MD )
Study ID Numbers:	DW6/2007
Study First Received:	June 19, 2008
Last Updated:	December 8, 2008
ClinicalTrials.gov Identifier:	NCT00705055
Health Authority:	Israel: Ministry of Health

Keywords provided by Carmel Medical Center:

Anthropometry
face recognition
genetic disease
newborn infant

Study placed in the following topic categories:

Genetic Diseases, Inborn
Facies

Additional relevant MeSH terms:

Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 16, 2009